Medical Technology

The revenue in Estonia's Medical Technology market market is forecasted to reach US$246.90m in 2024.
Among the various markets in the market, Medical Devices is the largest, with a projected market volume of US$208.50m in the same year.
Looking ahead, the revenue is expected to exhibit an annual growth rate of 5.16% between 2024 and 2029, resulting in a market volume of US$317.50m by 2029.
It is worth noting that in the global context, the United States is anticipated to generate the highest revenue, amounting to US$211.10bn in 2024.
Estonia's medical technology market is rapidly expanding, driven by its advanced digital infrastructure and government support for innovation.

Definition:
The Medical Technology market covers devices and products used for prevention, diagnosis, and treatment of diseases. Next to pharmaceuticals, they form the most important category of medical products. The most well known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants.

Structure:
The Medical Technology market consists of two markets, In Vitro Diagnostics (IVD) and Medical Devices. The IVD market covers products used for medical laboratory testing of specimens derived from the human body. The Medical Devices market covers a broad range of products which are further marketed into medical specialties or types of application: Cardiology Devices, Diagnostic Imaging Devices, Orthopedic Devices, Ophthalmic Devices, and General & Plastic Surgery Devices. The Other Medical Devices market provides information on additional areas that are not covered by the main markets.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers.
Further information on the key players can be found in the Market Shares boxes.

Implants and prostheses
Assistive technology products (e.g., hearing aids, wheelchairs)
Clinical engineering products
Imaging devices
Products for laboratoy testing (IVD)
Active medical devices (i.e., operating with electrical energy)

Pharmaceuticals
Services (i.e., treatment expenses)
Consumer technologies, e.g., fitness trackers
Blood and transplants derived from the human body

The Medical Technology market in Estonia has been experiencing significant growth in recent years, driven by customer preferences for advanced healthcare solutions and the country's commitment to technological innovation. Customer preferences in the Medical Technology market in Estonia are focused on products and services that offer advanced healthcare solutions. Estonian consumers are increasingly seeking out medical technologies that can improve the quality of their healthcare and provide more personalized treatment options. This includes a growing demand for wearable health devices, telemedicine services, and digital health platforms that allow for remote monitoring and consultation. Additionally, there is a strong preference for medical technologies that are user-friendly, efficient, and cost-effective. One of the key trends in the Medical Technology market in Estonia is the adoption of digital health technologies. The country has been actively investing in the development of digital health infrastructure and services, including electronic health records, telemedicine platforms, and mobile health applications. This trend is driven by the government's commitment to improving healthcare accessibility and quality through the use of technology. The increasing availability and affordability of smartphones and internet access have also contributed to the growth of digital health solutions in Estonia. Another trend in the Medical Technology market in Estonia is the growing focus on personalized medicine. Advances in genomic sequencing and biomarker identification have enabled healthcare providers to tailor treatment plans to individual patients based on their genetic makeup and specific health needs. This trend is driven by the desire to improve patient outcomes and reduce healthcare costs by providing targeted and effective treatments. The adoption of personalized medicine is supported by the country's strong research and development capabilities in the life sciences sector. Local special circumstances in Estonia contribute to the development of the Medical Technology market. The country has a well-established healthcare system, with a high level of healthcare infrastructure and a skilled workforce. This provides a conducive environment for the adoption and implementation of medical technologies. Additionally, Estonia has a strong culture of innovation and entrepreneurship, which has led to the emergence of several successful medical technology startups. The government's support for innovation and entrepreneurship through various funding programs and initiatives also plays a significant role in the growth of the Medical Technology market in Estonia. Underlying macroeconomic factors, such as the country's strong economic growth and increasing healthcare expenditure, also contribute to the development of the Medical Technology market in Estonia. The country's growing population and aging demographics create a greater demand for healthcare services and technologies. Furthermore, the government's commitment to healthcare reform and investment in healthcare infrastructure provides a favorable environment for the growth of the Medical Technology market. In conclusion, the Medical Technology market in Estonia is experiencing significant growth due to customer preferences for advanced healthcare solutions, the adoption of digital health technologies, the focus on personalized medicine, local special circumstances, and underlying macroeconomic factors. The country's commitment to technological innovation and its strong healthcare system provide a conducive environment for the development and adoption of medical technologies.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.